APIMEDS PHARMACEUTICALS US, INC. Crypto Asset Unrealized Gain Loss Nonoperating
APIMEDS PHARMACEUTICALS US, INC. (APUS) reported Crypto Asset Unrealized Gain Loss Nonoperating of -$13.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:CryptoAssetUnrealizedGainLossNonoperating · last filed 2026-08-14
- APIMEDS PHARMACEUTICALS US, INC. crypto asset unrealized gain loss nonoperating for the quarter ending 2026-06-30 was -$13.18M.
- APIMEDS PHARMACEUTICALS US, INC. crypto asset unrealized gain loss nonoperating for the quarter ending 2026-03-31 was -$22.08M.
- APIMEDS PHARMACEUTICALS US, INC. crypto asset unrealized gain loss nonoperating for fiscal 2025 was $6.01M.
| Period end | Crypto Asset Unrealized Gain Loss Nonoperating 3 month | Crypto Asset Unrealized Gain Loss Nonoperating 3 month as first filed | Crypto Asset Unrealized Gain Loss Nonoperating 6 month | Crypto Asset Unrealized Gain Loss Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$13.18M 10-Q · filed 2026-08-14 | -$35.26M 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | -$22.08M 10-Q · filed 2026-08-14 | -$22.06M 10-Q · filed 2026-05-26 | ||
| 2025-12-31 | $6.01M 10-K · filed 2026-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |